Telangana Life Sciences

Telangana, India’s youngest, has emerged as a leading life sciences hub in Asia housing more than 800 life sciences companies with a combined valued of USD 50 Bn. Telangana accounts for 1/3rd of global vaccine output and is regarded as the vaccine capital of the world. Also, the State contributes to about 35% of India’s pharmaceutical production.

Telangana has a rich mix of global majors like Novartis, Johnson & Johnson, GSK, Sanofi, Mylan, Nektar Therapeutics, Lonza, Ferring Pharmaceuticals, Dupont, Chemo, AMRI, etc. and is also home to a number of Indian multinationals including Dr. Reddy’s, Aurobindo, Hetero Drugs, MSN Labs, Bharat Biotech, Biological E, Indian Immunologicals, GVK Bio, Sai Lifesciences, Syngene, Laurus Labs, among others. State (Provincial) Government of Telangana continues to recognize life sciences as its priority sector. World-class infrastructure, progressive policies, cluster-based approach and availability of talent creates an enviable and unique identity for Hyderabad, which continues to attract major global and Indian Lifesciences’ companies to the State. Over the last five years, the sector has attracted about 900 greenfield investment projects worth US$ 2 billion.